Diego E. Álvarez

2.1k total citations
40 papers, 1.5k citations indexed

About

Diego E. Álvarez is a scholar working on Public Health, Environmental and Occupational Health, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Diego E. Álvarez has authored 40 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Public Health, Environmental and Occupational Health, 19 papers in Infectious Diseases and 11 papers in Molecular Biology. Recurrent topics in Diego E. Álvarez's work include Mosquito-borne diseases and control (19 papers), Insect symbiosis and bacterial influences (10 papers) and Viral Infections and Vectors (10 papers). Diego E. Álvarez is often cited by papers focused on Mosquito-borne diseases and control (19 papers), Insect symbiosis and bacterial influences (10 papers) and Viral Infections and Vectors (10 papers). Diego E. Álvarez collaborates with scholars based in Argentina, United States and France. Diego E. Álvarez's co-authors include Andrea V. Gamarnik, Claudia V. Filomatori, María F. Lodeiro, Lı́a I. Pietrasanta, Silvio J. Ludueña, Marcelo M. Samsa, Sergio M. Villordo, Hervé Agaisse, Néstor Gabriel Iglesias and Mariela Bollini and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Genes & Development.

In The Last Decade

Diego E. Álvarez

39 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Diego E. Álvarez Argentina 16 1.0k 721 369 346 280 40 1.5k
Claudia V. Filomatori Argentina 16 1.2k 1.2× 876 1.2× 472 1.3× 305 0.9× 271 1.0× 21 1.5k
Néstor Gabriel Iglesias Argentina 15 751 0.7× 561 0.8× 207 0.6× 345 1.0× 191 0.7× 23 1.3k
Julien Lescar Singapore 19 1.7k 1.7× 1.1k 1.6× 369 1.0× 510 1.5× 490 1.8× 24 2.4k
Mark Tilgner United States 14 1.1k 1.1× 823 1.1× 308 0.8× 215 0.6× 364 1.3× 14 1.5k
Aleksei Lulla Estonia 21 1.3k 1.3× 1.1k 1.6× 244 0.7× 339 1.0× 256 0.9× 35 1.9k
Sven Miller Germany 7 1.4k 1.4× 1.1k 1.6× 297 0.8× 497 1.4× 431 1.5× 7 2.5k
Qing-Yin Wang Singapore 18 1.3k 1.3× 912 1.3× 223 0.6× 529 1.5× 278 1.0× 19 1.9k
Eliana G. Acosta Germany 17 1.0k 1.0× 698 1.0× 216 0.6× 259 0.7× 222 0.8× 18 1.5k
Hélène Malet France 22 1.0k 1.0× 1.1k 1.5× 254 0.7× 768 2.2× 344 1.2× 32 2.5k
Joyce Jose United States 18 1.1k 1.1× 1.1k 1.5× 199 0.5× 416 1.2× 210 0.8× 39 2.2k

Countries citing papers authored by Diego E. Álvarez

Since Specialization
Citations

This map shows the geographic impact of Diego E. Álvarez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diego E. Álvarez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diego E. Álvarez more than expected).

Fields of papers citing papers by Diego E. Álvarez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Diego E. Álvarez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diego E. Álvarez. The network helps show where Diego E. Álvarez may publish in the future.

Co-authorship network of co-authors of Diego E. Álvarez

This figure shows the co-authorship network connecting the top 25 collaborators of Diego E. Álvarez. A scholar is included among the top collaborators of Diego E. Álvarez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Diego E. Álvarez. Diego E. Álvarez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alfonso, Victoria, Marco Demaria, Lorena M. Coria, et al.. (2024). A vaccine candidate based on baculovirus displaying chikungunya virus E1-E2 envelope confers protection against challenge in mice. Journal of Virology. 98(11). e0101724–e0101724.
2.
Noval, María G., et al.. (2024). Changes in the chikungunya virus E1 glycoprotein domain II and hinge influence E2 conformation, infectivity, and virus-receptor interactions. Journal of Virology. 98(7). e0067924–e0067924. 3 indexed citations
3.
Jar, Ana María, et al.. (2024). An Outbreak of SARS-CoV-2 in Captive Armadillos Associated with Gamma Variant in Argentina. EcoHealth. 21(2-4). 183–194. 1 indexed citations
4.
Castellano, Luciana Andrea, et al.. (2024). Dengue virus preferentially uses human and mosquito non-optimal codons. Molecular Systems Biology. 20(10). 1085–1108. 7 indexed citations
5.
Álvarez, Diego E., et al.. (2024). New Highly Selective Antivirals for Chikungunya Virus identified from the Screening of a Drug-Like Compound Library. Current Microbiology. 81(10). 343–343. 1 indexed citations
6.
Suzuki, Yasutsugu, et al.. (2024). Molecular basis of RNA recombination in the 3′UTR of chikungunya virus genome. Nucleic Acids Research. 52(16). 9727–9744. 1 indexed citations
7.
Cosseau, Céline, Elisa Bergami, César A. Cárdenas, et al.. (2024). Exposure to nanoplastics and nanomaterials either single and combined affects the gill-associated microbiome of the Antarctic soft-shelled clam Laternula elliptica. Marine Environmental Research. 198. 106539–106539. 9 indexed citations
8.
Álvarez, Diego E., et al.. (2023). A COVID-19 vaccine candidate based on SARS-CoV-2 spike protein and immune-stimulating complexes. Applied Microbiology and Biotechnology. 107(11). 3429–3441. 3 indexed citations
9.
Vota, Daiana, Alejandro R. Parise, Leonardo Romorini, et al.. (2023). Broad-Spectrum Antiviral Effect of Cannabidiol Against Enveloped and Nonenveloped Viruses. Cannabis and Cannabinoid Research. 9(3). 751–765. 6 indexed citations
10.
Álvarez, Diego E., et al.. (2023). Design and characterization of chimeric Rabies-SARS-CoV-2 virus-like particles for vaccine purposes. Applied Microbiology and Biotechnology. 107(11). 3495–3508. 4 indexed citations
11.
Pascual, M., et al.. (2023). Unveiling tetrahydroquinolines as promising BVDV entry inhibitors: Targeting the envelope protein. Virology. 590. 109968–109968. 2 indexed citations
13.
Panei, Carlos Javier, et al.. (2022). Serological evidence of SARS-CoV-2 infection in pets naturally exposed during the COVID-19 outbreak in Argentina. Veterinary Immunology and Immunopathology. 254. 110519–110519. 6 indexed citations
14.
Álvarez, Diego E., et al.. (2018). Identification of (4-(9H-fluoren-9-yl) piperazin-1-yl) methanone derivatives as falcipain 2 inhibitors active against Plasmodium falciparum cultures. Biochimica et Biophysica Acta (BBA) - General Subjects. 1862(12). 2911–2923. 12 indexed citations
16.
Pascual, M., et al.. (2017). Structure-based drug design for envelope protein E2 uncovers a new class of bovine viral diarrhea inhibitors that block virus entry. Antiviral Research. 149. 179–190. 21 indexed citations
17.
Borinskaya, Sofya, Katrina Velle, Kenneth G. Campellone, et al.. (2015). Integration of linear and dendritic actin nucleation in Nck-induced actin comets. Molecular Biology of the Cell. 27(2). 247–259. 11 indexed citations
18.
Filomatori, Claudia V., Néstor Gabriel Iglesias, Sergio M. Villordo, Diego E. Álvarez, & Andrea V. Gamarnik. (2010). RNA Sequences and Structures Required for the Recruitment and Activity of the Dengue Virus Polymerase. Journal of Biological Chemistry. 286(9). 6929–6939. 91 indexed citations
19.
Álvarez, Diego E., Claudia V. Filomatori, & Andrea V. Gamarnik. (2008). Functional analysis of dengue virus cyclization sequences located at the 5′ and 3′UTRs. Virology. 375(1). 223–235. 115 indexed citations
20.
Álvarez, Diego E., et al.. (2005). Role of RNA structures present at the 3′UTR of dengue virus on translation, RNA synthesis, and viral replication. Virology. 339(2). 200–212. 232 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026